FindTrial
Sign In

Hepatitis B infection and its outcomes of in vitro fertilization and embryo transfer treatment

Hepatitis B infection and its outcomes of in vitro fertilization and embryo transfer treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-13003106
Enrollment
Unknown
Registered
2013-03-16
Start date
2013-02-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Nil:Nil

Sponsors

Nil
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Couples had the in vitro fertilization and embryo transfer cycle during the period from 2007 to 2011 in the assisted reproductive unit, the tertiary referral center affiliated with the department of obstetrics and gynecology, the chinese university of hong kong.

Exclusion criteria

Exclusion criteria: if the inclusion criteria are not satisfied

Design outcomes

Primary

MeasureTime frame
prevalence of HBV infection among the population with subfertility;controlled ovarian hyperstimulation;outcome of IVF or ET (embryology data, such as ovarian reserve assessment, fertilization rate, pregnancy rate);—

Countries

China

Contacts

Public ContactDr. Wing Shan Kong
gracekong@cuhk.edu.hk+852 2632 2996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026